Silk Road Medical, Inc

    Silk Road Medical, Inc

    NNASDAQ:SILK
    27.49
    USD
    0.00
    (0.00%)
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    0.59
    1.2
    2.76
    2.28
    2.93
    3.88
    4.56
    4.88
    Basic EPS, GAAP
    -0.8
    -1.31
    -2.28
    -1.44
    -1.44
    -1.54
    -1.44
    -1.44
    Free Cash Flow per Basic Share
    -1.07
    -0.83
    -1.31
    -1.3
    -1.26
    -1.05
    -0.86
    -0.92
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -4.22
    -4.85
    -8.34
    -7.25
    -8.33
    -9.61
    -10.29
    -10.96
    Tangible Book Value per Share
    -4.1
    -4.69
    3.13
    3.26
    2.29
    4.58
    3.9
    3.94
    Basic Weighted Avg Shares
    24
    29
    23
    33
    35
    36
    39
    39
    Sales/Revenue/Turnover
    14
    35
    63
    75
    101
    139
    177
    191
    Operating Margin (%)
    -128.87
    -61.91
    -44.3
    -56.97
    -46.78
    -37.51
    -33.46
    -31.43
    Depreciation Expense
    - -
    1
    1
    1
    2
    3
    4
    4
    Net Income, GAAP
    -19
    -38
    -52
    -47
    -50
    -55
    -56
    -57
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -135.76
    -108.89
    -82.73
    -62.96
    -49.09
    -39.68
    -31.47
    -29.53
    Working Capital
    37
    28
    96
    154
    117
    230
    211
    209
    LT Debt
    28
    44
    45
    49
    45
    75
    76
    76
    Total Equity
    -99
    -135
    72
    108
    79
    164
    151
    155
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    2
    2
    2
    LT Borrowings
    76
    76
    76
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    39
    39
    41
    Market Capitalization
    475
    714
    1,061

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    241
    236
    241
    Cash, Cash Equivalents & STI
    181
    174
    172
    Accounts Receivable, Net
    24
    27
    26
    Inventories
    30
    30
    30
    Total Current Liabilities
    30
    21
    32
    Payables & Accruals
    28
    19
    29
    ST Debt
    2
    2
    2
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -6.23%
    -7.76%
    Free Cash Flow
    - -
    9.03%
    -10.82%
    Net Income, GAAP
    - -
    9.32%
    1.33%
    Sales/Revenue/Turnover
    - -
    40.27%
    27.77%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    28
    33
    37
    40
    139
    2023
    40
    45
    44
    47
    177
    2024
    48
    51
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.48
    -0.44
    -0.29
    -0.34
    -1.54
    2023
    -0.43
    -0.35
    -0.33
    - -
    -1.44
    2024
    -0.36
    -0.42
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • prnewswire.com

      Boston Scientific Announces Results for Third Quarter 2024

    • prnewswire.com

      Boston Scientific Closes Acquisition of Silk Road Medical, Inc.

    • accesswire.com

      SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY and SILK on Behalf of Shareholders

    • globenewswire.com

      SILK INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger and Looming Vote on September 5, 2024, of Silk Road Medical, Inc.

    • prnewswire.com

      SILK INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger and Looming Vote on September 5, 2024, of Silk Road Medical, Inc.

    • globenewswire.com

      SILK Alert: Monsey Firm of Wohl & Fruchter Renews Investigation of the Proposed Sale of Silk Road Medical to Boston Scientific

    • zacks.com

      Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates

    • globenewswire.com

      Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures

    • prnewswire.com

      SILK INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger of Silk Road Medical, Inc.

    • globenewswire.com

      STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Silk Road Medical, Inc. – SILK

    • prnewswire.com

      STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Silk Road Medical, Inc. - SILK

    • globenewswire.com

      SILK Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Silk Road Medical to Boston Scientific

    • businesswire.com

      SILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILK

    • zacks.com

      Strength Seen in Silk Road Medical (SILK): Can Its 24.0% Jump Turn into More Strength?

    • prnewswire.com

      ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.

    • prnewswire.com

      Shareholder Alert: Ademi LLP investigates whether Silk Road Medical, Inc. has obtained a Fair Price for its Public Shareholders

    • investors.com

      Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover

    • benzinga.com

      Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal

    • investorplace.com

      Why Is Silk Road Medical (SILK) Stock Up 24% Today?

    • globenewswire.com

      Breaking News: Is Silk Road Medical's $27.50 Per Share Sale Price a Fair Deal? Johnson Fistel, LLP Investigates Deal Terms